Clinical Trial Update: Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Abiraterone Acetate in combination with Darxicilib or Dalpicilib for metastatic castration-resistant prostate cancer; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Dalpicilib
• Darxicilib

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING